Serina Therapeutics (SER) Assets (2017 - 2026)
Serina Therapeutics (SER) posted Assets of $7.0 million for Q4 2025, down 44.0% sequentially from $12.4 million in Q3 2025, and up 3.38% YoY from $6.7 million in Q4 2024.
Serina Therapeutics (SER) Assets (2017 - 2026) Analysis & Trends
Serina Therapeutics has reported Assets for 9 years, with the latest figure at $7.0 million in Q4 2025.
- Quarterly Assets rose 3.38% year-over-year to $7.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.0 million (up 3.38% YoY) and the FY2025 annual result came in at $7.0 million, up 3.38% from the prior year.
- Assets retreated to $7.0 million in Q4 2025 per SER's latest filing, from $12.4 million in the prior quarter.
- Over five years, Assets peaked at $12.4 million in Q3 2025 and troughed at $497000.0 in Q1 2023.
- A 5-year average of $5.7 million and a median of $5.0 million in 2022 frame the typical range for Assets.
- The sharpest annual moves came in 2023 and 2024: Assets tumbled 81.7% in 2023, then surged 2084.31% in 2024.
- Over 5 years, Assets stood at $3.2 million in 2021, then increased by 2.76% to $3.2 million in 2022, then jumped by 176.7% to $9.0 million in 2023, then slipped by 25.02% to $6.7 million in 2024, then increased by 3.38% to $7.0 million in 2025.
- According to Business Quant data, Assets over the past three periods registered $7.0 million, $12.4 million, and $8.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.57 Bn | 131.72 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 65.44 Bn | 60.25 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 60.06 Bn | 54.93 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.89 Bn | 28.58 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.11 Bn | 9.72 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 19.82 Bn |
| 10 | Serina Therapeutics | 44.50 Mn | 21.48 Mn | - | 25.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.81 Mn |
| Dec 31, 2025 | 6.95 Mn |
| Sep 30, 2025 | 12.41 Mn |
| Jun 30, 2025 | 8.94 Mn |
| Mar 31, 2025 | 6.73 Mn |
| Dec 31, 2024 | 6.72 Mn |
| Sep 30, 2024 | 7.44 Mn |
| Jun 30, 2024 | 10.71 Mn |
| Mar 31, 2024 | 10.86 Mn |
| Dec 31, 2023 | 8.97 Mn |
| Sep 30, 2023 | 12.21 Mn |
| Jun 30, 2023 | 497,000.00 |
| Mar 31, 2023 | 497,000.00 |
| Dec 31, 2022 | 3.24 Mn |
| Sep 30, 2022 | 2.01 Mn |
| Jun 30, 2022 | 2.58 Mn |
| Mar 31, 2022 | 2.72 Mn |
| Dec 31, 2021 | 3.15 Mn |
| Sep 30, 2021 | 2.43 Mn |
| Jun 30, 2021 | 2.54 Mn |